Book a demo
Presence & RecognitionEvent: September 4, 2026

Johnson & Johnson Innovative Medicine was named a finalist for the 2026 SCRS Eagle Award

Published

Signal category

Presence & Recognition

Quote

Johnson & Johnson has been named a finalist for the 2026 SCRS Eagle Award

Channia L. Holt|Johnson & Johnson Innovative Medicine team

Company

Industry
Pharmaceutical Manufacturing
Company size
39,024 employees

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.